[
  {
    "ts": "2026-01-07T12:37:05+00:00",
    "headline": "BofA double-upgrades Regeneron, citing stronger Eylea outlook and 2026 catalysts",
    "summary": "Investing.com -- Bank of America has shifted its stance on Regeneron, raising the stock two notches to Buy from Underperform and lifting its price objective to $860 in a note on Wednesday.",
    "url": "https://finance.yahoo.com/news/bofa-double-upgrades-regeneron-citing-123705345.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "b727f67c-52ab-3b03-9e15-7e7952ba9a42",
      "content": {
        "id": "b727f67c-52ab-3b03-9e15-7e7952ba9a42",
        "contentType": "STORY",
        "title": "BofA double-upgrades Regeneron, citing stronger Eylea outlook and 2026 catalysts",
        "description": "",
        "summary": "Investing.com -- Bank of America has shifted its stance on Regeneron, raising the stock two notches to Buy from Underperform and lifting its price objective to $860 in a note on Wednesday.",
        "pubDate": "2026-01-07T12:37:05Z",
        "displayTime": "2026-01-07T12:37:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bofa-double-upgrades-regeneron-citing-123705345.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bofa-double-upgrades-regeneron-citing-123705345.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T13:30:00+00:00",
    "headline": "BrightInsight’s Patient App, developed with Sanofi, shows positive impact in patient treatment adherence and persistence",
    "summary": "SAN JOSE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- BrightInsight, Inc. (“BrightInsight”), a leader in digital health solutions, today shared new data from its collaboration with Sanofi and its partner, Regeneron, highlighting the positive impact of the Patient App on adherence and persistence for one of Sanofi and Regeneron’s key biologic therapies. Adherence remains a major challenge for the pharmaceutical industry—particularly with self-injected therapies administered at home. Despite substan",
    "url": "https://finance.yahoo.com/news/brightinsight-patient-app-developed-sanofi-133000579.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "37838c10-a62d-35ae-9e44-74f846204c2c",
      "content": {
        "id": "37838c10-a62d-35ae-9e44-74f846204c2c",
        "contentType": "STORY",
        "title": "BrightInsight’s Patient App, developed with Sanofi, shows positive impact in patient treatment adherence and persistence",
        "description": "",
        "summary": "SAN JOSE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- BrightInsight, Inc. (“BrightInsight”), a leader in digital health solutions, today shared new data from its collaboration with Sanofi and its partner, Regeneron, highlighting the positive impact of the Patient App on adherence and persistence for one of Sanofi and Regeneron’s key biologic therapies. Adherence remains a major challenge for the pharmaceutical industry—particularly with self-injected therapies administered at home. Despite substan",
        "pubDate": "2026-01-07T13:30:00Z",
        "displayTime": "2026-01-07T13:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/7bf6d64024cea11d157d23ccdbcbdc5f",
          "originalWidth": 300,
          "originalHeight": 42,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QnbO5_qiY2aw5uoiOMDSnA--~B/aD00Mjt3PTMwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7bf6d64024cea11d157d23ccdbcbdc5f.cf.webp",
              "width": 300,
              "height": 42,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/N0i_9LawFZoTamUIpI2gNw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/7bf6d64024cea11d157d23ccdbcbdc5f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/brightinsight-patient-app-developed-sanofi-133000579.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/brightinsight-patient-app-developed-sanofi-133000579.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SNY"
            },
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]